iNovation® Day is the innovation forum preceding the main ESCRS Congress, bringing together doctors, industry leaders, investors, and emerging companies to showcase breakthrough technologies in ophthalmology.
“As part of iNovation, we were honored to see the community recognize SimVis Gekko’s real potential,” said Prof. Susana Marcos. “Earning 69% of votes confirms that visual simulation is not just a concept — it’s becoming a clinical imperative.”
This recognition underscores how SimVis Gekko bridges advanced optics and clinical decision-making, helping ophthalmologists and patients preview vision outcomes with different IOLs before surgery. Its intuitive, binocular simulation brings clarity, trust, and precision to preoperative consultations.
Why this matters
– Community validation: Being voted top emerging technology by peers highlights the trust and expectation placed in SimVis Gekko’s future relevance.
– Clinical relevance: The technology is not just theoretical; it delivers tangible support in IOL counseling, expectation management, and patient satisfaction.
– Strategic momentum: This award strengthens 2EyesVision’s positioning as a front-runner in ophthalmic innovation and reinforces confidence from clinicians, partners, and investors.
About ESCRS iNovation® Day
ESCRS iNovation® Day is held immediately before the ESCRS Congress and focuses on innovation, emerging companies, and future trends in ophthalmology. In 2025, it took place on 12 September at the Bella Center, Copenhagen.
Want to learn more?
Discover how SimVis Gekko is shaping ophthalmology:
Interested in investing in 2EyesVision?
Visit our Investors Page:
